CTI Biopharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsCTI Biopharma

CTI Biopharma(CTIC)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Vonjo	Pacritinib	2022-02-28	2028-2030	Primary myelofibrosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

neoplasm metastasis

,

meningeal neoplasms

,

meningeal carcinomatosis

,

hodgkin disease

Aglatimagene besadenovec

,

prostatic neoplasms

,

gastrointestinal diseases

,

digestive system diseases

,

,

immunoglobulin light-chain amyloidosis

,

smoldering multiple myeloma

,

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

myelodysplastic syndromes

,

myelomonocytic leukemia chronic

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

lymphoid leukemia

,

b-cell lymphoma

,

second primary neoplasms

,

neoplasm metastasis

,

myeloid leukemia acute

,

myeloid leukemia

,

non-hodgkin lymphoma

,

,

follicular lymphoma

,

b-cell chronic lymphocytic leukemia

,

large b-cell lymphoma diffuse

,

,

,

b-cell lymphoma marginal zone

postoperative pain

diabetes mellitus

,

diabetic neuropathies

,

,

attention deficit disorder with hyperactivity

renal insufficiency

,

multiple myeloma

,

plasma cell neoplasms

,

hyperlipidemias

,

,

,

neoplasm metastasis

,

chronic kidney failure

,

kidney diseases

,

hyperparathyroidism

,

secondary hyperparathyroidism

,

,

chronic renal insufficiency

,

vascular calcification

,

cardiovascular diseases

,

stomach neoplasms

,

brain neoplasms

,

pancreatic neoplasms

,

,

,

cholangiocarcinoma

,

hepatocellular carcinoma

,

liver neoplasms

,

,

triple negative breast neoplasms

,

urinary bladder neoplasms

,

urinary bladder diseases

,

renal cell carcinoma

,

neoplasm metastasis

,

transitional cell carcinoma

,

hodgkin disease

,

meningeal neoplasms

,

non-small-cell lung carcinoma

,

colorectal neoplasms

,

,

,

rectal neoplasms

,

pancreatic ductal carcinoma

,

large b-cell lymphoma diffuse

,

colonic neoplasms

,

,

,

b-cell lymphoma

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

rectal diseases

,

gastrointestinal diseases

,

intestinal neoplasms

,

digestive system diseases

,

colonic diseases

,

intestinal diseases

,

non-hodgkin lymphoma

,

,

drug-related side effects and adverse reactions

,

,

male breast neoplasms

,

hand-foot syndrome

,

acquired immunodeficiency syndrome

,

breast neoplasms

,

,

,

,

,

breast neoplasms

,

non-hodgkin lymphoma

,

colorectal neoplasms

postoperative nausea and vomiting

,

,

viral hepatitis human

,

,

neurologic manifestations

,

brain neoplasms

,

,

,

biliary tract neoplasms

,

,

follicular lymphoma

,

,

microsatellite instability

,

squamous cell neoplasms

,

large cell carcinoma

,

chronic obstructive pulmonary disease

,

,

cholangiocarcinoma

,

,

mouth neoplasms

,

oropharyngeal neoplasms

,

laryngeal neoplasms

,

hypopharyngeal neoplasms

,

b-cell lymphoma marginal zone

,

mantle-cell lymphoma

,

endometrial neoplasms

,

transitional cell carcinoma

,

uterine cervical neoplasms

,

cutaneous malignant melanoma

,

type 2 diabetes mellitus

,

diabetes mellitus

,

non-small-cell lung carcinoma

,

,

,

,

breast neoplasms

,

,

communicable diseases

,

,

chronic hepatitis c

,

,

,

neoplasm metastasis

,

,

colorectal neoplasms

,

stomach neoplasms

,

triple negative breast neoplasms

,

,

squamous cell carcinoma of head and neck

,

esophageal neoplasms

,

ovarian neoplasms

,

,

chronic hepatitis

,

,

,

squamous cell carcinoma

,

head and neck neoplasms

,

sleep initiation and maintenance disorders

,

,

clostridium infections

,

multiple myeloma

,

plasma cell neoplasms

,

hodgkin disease

,

,

ovarian epithelial carcinoma

,

migraine disorders

,

castration-resistant prostatic neoplasms

,

pancreatic neoplasms

,

,

essential hypertension

,

nasopharyngeal neoplasms

,

acquired immunodeficiency syndrome

,

,

chronic renal insufficiency

,

kidney diseases

,

hepatocellular carcinoma

,

general anesthesia

,

neuromuscular blockade

,

intraabdominal infections

,

urinary tract infections

,

malignant mesothelioma

,

,

postmenopausal osteoporosis

,

hypercholesterolemia

,

alzheimer disease

,

,

erectile dysfunction

,

renal cell carcinoma

,

surgical wound infection

,

bacterial skin diseases

,

bacterial infections

,

staphylococcal infections

,

,

immunologic deficiency syndromes

,

urinary bladder neoplasms

,

,

type 1 diabetes mellitus

,

cytomegalovirus infections

,

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

allergic rhinitis

,

,

allergic rhinitis seasonal

,

liver neoplasms

,

fallopian tube neoplasms

,

,

,

bacterial pneumonia

,

,

,

,

,

hepatic insufficiency

,

,

prostatic hyperplasia

,

,

,

cognitive dysfunction

,

,

,

prostatic neoplasms

,

plexiform neurofibroma

,

neurofibromatosis 1

,

hereditary breast and ovarian cancer syndrome

,

,

central nervous system neoplasms

,

nervous system neoplasms

,

rheumatoid arthritis

,

,

hip osteoarthritis

,

surgical blood loss

,

replacement arthroplasty hip

1

2

3

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use